Tillkännagivande • Jul 31
Frequency Exchange Corp. announced that it expects to receive CAD 2 million in funding Frequency Exchange Corp announced a non-brokered private placement to issue 8,000,000 units at an issue price of CAD 0.25 for the proceeds of CAD 2,000,000 on July 31, 2026. Each unit comprising one common share and one-half common share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share at CAD 0.40 for a period of 12 months, subject to approval of the TSX Venture Exchange. Closing may occur in tranches, with the first tranche expected to close on or about August 14, 2026. New Risk • Jun 19
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$13.6m (US$9.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.4m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Revenue is less than US$1m (CA$745k revenue, or US$526k). Market cap is less than US$10m (CA$13.6m market cap, or US$9.56m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding). New Risk • Apr 26
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.2m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue is less than US$1m (CA$886k revenue, or US$649k). Minor Risks Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (CA$16.3m market cap, or US$11.9m). Tillkännagivande • Apr 21
Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026 Frequency Exchange Corp., Annual General Meeting, Jun 16, 2026. Location: british columbia, vancouver Canada New Risk • Feb 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$11.6m (US$8.56m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Revenue is less than US$1m (CA$1.1m revenue, or US$828k). Market cap is less than US$10m (CA$11.6m market cap, or US$8.56m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding). Board Change • Jan 02
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Tillkännagivande • Dec 20
Frequency Exchange Corp. Announces the Appointment of Sammy Chow to Its Advisory Board Frequency Exchange Corp. announced the appointment of Sammy Chow to its Advisory Board. Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy. Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions. Sammy adds valuable capital markets and operational depth to leadership group. Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA). Tillkännagivande • Dec 18
Frequency Exchange Corp. Announces the Appointment of Gail Edgell to Its Advisory Board Frequency Exchange Corp. announced the appointment of Gail Edgell to its Advisory Board. Gail Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement, and education-based commercialization, contributing to consistent revenue growth across several companies. Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5 million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1 million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech startup, and has advised numerous integrative health clinics on operational growth and patient education strategies. Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former nonprofit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and healthcare educators to reimagine practitioner support experiences. Tillkännagivande • Dec 15
Frequency Exchange Corp Appoints Michael Moe To Advisory Board Frequency Exchange Corp. has appointed Michael Moe to its Advisory Board. Michael Moe is the Founder and CEO of GSV. He is also the co-founder of the ASU+GSV Summit, which Forbes referred to as the Davos of Education, and has contributed to expanding global interest in the digital learning and wellness sectors through GSV's various funds and partnerships. Mr. Moe previously served as Head of Global Growth Research at Merrill Lynch and was named to the Institutional Investor All-America Research Team. He also founded ThinkEquity Partners and has authored several books on entrepreneurship and impact-focused investing. Michael holds a BA in Political Science and Economics from the University of Minnesota and is a CFA charterholder. Reported Earnings • Nov 21
Third quarter 2025 earnings released: CA$0.016 loss per share (vs CA$0.005 loss in 3Q 2024) Third quarter 2025 results: CA$0.016 loss per share (further deteriorated from CA$0.005 loss in 3Q 2024). Revenue: CA$170.0k (down 23% from 3Q 2024). Net loss: CA$796.0k (loss widened 256% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Sep 25
Frequency Exchange Corp. announced that it has received CAD 1.838034 million in funding On September 24, 2025, Frequency Exchange Corp. closed the transaction. The company issued an additional 3,418,031 units at a price of CAD 0.25 per unit for proceeds of CAD 854,507.75 in second and final tranche, bringing the total private placement to 7,352,133 units for aggregated proceeds of CAD 1,838,033.25 when combined with the first-tranche closing. Each unit consisted of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of issuance. The company issued 72,800 non-transferable finder warrants and paid a cash commission of CAD 18,200 to Canaccord Genuity Corp. The finder warrants are at an exercise price of CAD 0.40 per share for a period of 24 months from the date of issuance and are subject to the same acceleration clause as the warrants. All securities issued in connection with the second tranche of the private placement are subject to a statutory hold period expiring January 25, 2026. New Risk • Sep 25
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$845k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$17.5m market cap, or US$12.6m). New Risk • Aug 28
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$689k). Revenue is less than US$1m (CA$1.2m revenue, or US$852k). Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$18.4m market cap, or US$13.3m). Reported Earnings • Aug 26
Second quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 2Q 2024) Second quarter 2025 results: CA$0.003 loss per share (improved from CA$0.005 loss in 2Q 2024). Revenue: CA$250.2k (down 5.5% from 2Q 2024). Net loss: CA$122.0k (loss narrowed 45% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jul 22
Frequency Exchange Corp. announced that it expects to receive CAD 1.5 million in funding Frequency Exchange Corp. announced a private placement to issue 6,000,000 units at an issue price of CAD 0.25 per unit for gross proceeds of CAD 1,500,000 on July 21, 2025. Each unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per warrant and a term of 24 months from the date of closing of the private placement. Finders’ fees of up to 8% cash and 8% finders’ warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval, and all securities issued will be subject to a four-month hold period. Board Change • Jun 04
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. New Risk • May 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$724k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$724k free cash flow). Shares are highly illiquid. Negative equity (-CA$623k). Revenue is less than US$1m (CA$1.2m revenue, or US$867k). Market cap is less than US$10m (CA$11.0m market cap, or US$8.05m). New Risk • May 29
New major risk - Revenue and earnings growth Earnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$444k). Earnings have declined by 4.1% per year over the past 5 years. Revenue is less than US$1m (CA$1.0m revenue, or US$758k). Market cap is less than US$10m (CA$11.0m market cap, or US$7.99m). Reported Earnings • May 23
First quarter 2025 earnings released: CA$0.004 loss per share (vs CA$0.012 loss in 1Q 2024) First quarter 2025 results: CA$0.004 loss per share (improved from CA$0.012 loss in 1Q 2024). Revenue: CA$275.5k (up 107% from 1Q 2024). Net loss: CA$188.5k (loss narrowed 63% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Mar 11
Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in funding Frequency Exchange Corp. announced a private placement of up to 2,000,000 units at a price of CAD 0.25 per unit for gross proceeds of CAD 500,000 on March 10, 2025. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.40 per Warrant and a term of 24 months from the date of closing f the Private Placement. Finders’ fees of up to 6% cash and 6% finders’ warrants, having the same terms as the Warrants, may be paid if applicable in respect of the private placement closing. The Private Placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period. Board Change • Feb 28
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 6 experienced directors. No highly experienced directors. Chairman, President & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. New Risk • Nov 27
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$834k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$834k free cash flow). Shares are highly illiquid. Negative equity (-CA$325k). Earnings have declined by 8.1% per year over the past 5 years. Revenue is less than US$1m (CA$880k revenue, or US$627k). Market cap is less than US$10m (CA$13.7m market cap, or US$9.79m). Minor Risk Shareholders have been diluted in the past year (14% increase in shares outstanding). Reported Earnings • Nov 27
Third quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 3Q 2023) Third quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 3Q 2023). Revenue: CA$221.7k (up 39% from 3Q 2023). Net loss: CA$223.7k (loss narrowed 37% from 3Q 2023). Tillkännagivande • Nov 22
Cam Neely Joins Frequency Exchange Advisory Board Frequency Exchange Corp. announce former NHL star, Hockey Hall of Fame Inductee and President of the Boston Bruins Cam Neely will be joining its Advisory Board, to play a strategic role as the Company enters its next phase of growth. Mr. Neely was a power forward for the Vancouver Canucks and Boston Bruins from 1983-96. He was inducted into the Hockey Hall of Fame in 2005 and was appointed Vice President of the Boston Bruins in 2007. In 2010 he assumed his current role as President of the Bruins. Mr. Neely is also President of the Cam Neely Foundation, a non-profit organization comprised of the Neely Cancer Fund, which raises money in support of cancer research and treatment, and Neely House, an organization providing accommodation, community, and support to cancer patients and their families during treatment. He also sat on the Board of Directors of Whistler Blackcomb Holdings Inc., the holding company for Whistler Blackcomb Ski Resort, before it was acquired by Vail Resorts Inc. in 2016. Tillkännagivande • Sep 19
Frequency Exchange Corp. announced that it has received CAD 0.763077 million in funding On September 18, 2024, Frequency Exchange Corp. closed the transaction. The company issued an additional1,866,667 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 280,000, bringing the total private placement to 5,087,178 units for aggregated proceeds of CAD 763,077 when combined with the two previous closings subject to final approval from the TSX Venture Exchange. In connection with the closing of the final tranche, the company issued 60,000 finder's warrants having the same terms as the warrants and paid a cash commission of CAD 9,000 to Canaccord Genuity Corp. Tillkännagivande • Sep 17
Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024 Frequency Exchange Corp., Annual General Meeting, Nov 13, 2024. Location: british columbia, vancouver Canada New Risk • Aug 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$711k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$711k free cash flow). Shares are highly illiquid. Negative equity (-CA$551k). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (CA$817k revenue, or US$607k). Market cap is less than US$10m (CA$6.37m market cap, or US$4.72m). Minor Risk Shareholders have been diluted in the past year (9.5% increase in shares outstanding). Reported Earnings • Aug 31
Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.009 loss in 2Q 2023) Second quarter 2024 results: CA$0.005 loss per share (improved from CA$0.009 loss in 2Q 2023). Revenue: CA$264.8k (up 37% from 2Q 2023). Net loss: CA$223.4k (loss narrowed 32% from 2Q 2023). Reported Earnings • Jun 04
First quarter 2024 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 1Q 2023) First quarter 2024 results: CA$0.012 loss per share (further deteriorated from CA$0.011 loss in 1Q 2023). Revenue: CA$133.3k (down 39% from 1Q 2023). Net loss: CA$505.1k (loss widened 26% from 1Q 2023). Reported Earnings • Apr 25
Full year 2023 earnings released: CA$0.037 loss per share (vs CA$0.14 loss in FY 2022) Full year 2023 results: CA$0.037 loss per share (improved from CA$0.14 loss in FY 2022). Revenue: CA$829.7k (up 19% from FY 2022). Net loss: CA$1.44m (loss narrowed 71% from FY 2022). Tillkännagivande • Apr 18
Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in funding Frequency Exchange Corp. announced a private placement of up to 3,333,333 units at a price of CAD 0.15 per unit for gross proceeds of up to CAD 499,999.95 on April 17, 2024. Each Unit is comprised of one common share and one common share purchase warrant having an exercise price of CAD 0.25 per warrant and a term of 24 months from the date of closing of the Private Placement. In the event that, during the 24 month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.40 per Common Share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of news release. Finders' fees of up to 6% cash and 6% finders' warrants, having the same terms as the warrants, may be paid if applicable in respect of the private placement closing. The private placement is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period. Reported Earnings • Dec 01
Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2022) Third quarter 2023 results: CA$0.01 loss per share (improved from CA$0.013 loss in 3Q 2022). Revenue: CA$159.1k (up 29% from 3Q 2022). Net loss: CA$354.3k (loss narrowed 23% from 3Q 2022). Tillkännagivande • Nov 21
Frequency Exchange Corp.'s Subsidiary Fremedica Technologies Inc. Announces Appointment to Advisory Board Frequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has increased its team by adding two key roles. As Corporate Ambassador and Director of Business Development, Allison Butenschon will oversee development of opportunities now opened with expansion of its rights. Alexandra Moresco becomes its PR and Social Media director responsible for growing NIKKI awareness and demand across all of its communications platforms. Allison Butenschon, Director of Business Development: Allison Butenschon is an entrepreneur with a diverse and colourful career. Her health and wellness journey began with a personal battle against Lyme disease contracted at age 18. This challenging experience shaped her life and inspired her to help others facing similar emotional and physical devastation. Despite her disease, Allison has made significant contributions as a clothing, interior and lifestyle designer. She has also been instrumental in commercial and residential building development, demonstrating her business skills as an innovative thinker and leader. With her unique blend of expertise in alternative health, design, and business development, Allison continues to inspire and empower individuals to overcome adversity and pursue their dreams. Alexandra Moresco, Public Relations and Social Media Director: When Alexandra was stricken with Lyme disease, she shifted the focus of her entertainment and talent relations company to helping other Lyme sufferers and creating partnerships to find a cure. With degrees in public relations, advertising and journalism, she adds her personal experience living with chronic disease to build long-lasting relations with both media and patient communities. Alexandra works with companies including Nike, Complex Magazine and Facebook Watch-now, boasting a client roster of top tier medical, healthcare and wellness clients. She has raised hundreds of thousands of dollars for tick-borne illness research and over the past year has secured over 250 prominent placements with media readership equating to a billion viewers. Tillkännagivande • Nov 14
FREmedica Technologies Inc. Announces Advisory Board Appointments Frequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. (FREmedica), has increased its team with the addition of Linda Fontana (Business Development), Andy Parkins (Operations & Systems Development) and Dale Maclean (Public Market Strategies.) These new appointments bring further vision and expertise to the company's advisory resource. Linda Fontana- Corporate Consultant and Coach: Since 1988, Linda's career path has taken her to a wide array of occupations in Canada and the United States. She has been a business owner, consultant, speaker and business training development and recruitment specialist. Married with a daughter, she lost her 38 year-old husband Brian to ALS in 2003. Linda became inspired to help those with ALS lead better and more meaningful lives and ultimately find a cure. As a passionate wellness advocate, Linda is a welcome addition to the FREmedica advisory board and a worthy representative of its corporate and personal values. Dale R. MacLean, MBA-Business Management Leader: Dale is a strategic, innovative and results-driven leader with a track record of optimizing shareholder value. As CEO of Tree Island Steel he guided a 78% growth from 132 million to 235 million. Dale understands and works effectively with regulators, boards, Investment communities, elected Officials, community leaders, First Nations Leaders, labour leaders and the Media. He brings proven expertise in growing and running medium-large, complex, international businesses. Dale's experience in commercial and operational transactions and business management throughout North America, Asia and the Pacific Rim will factor in establishing and growing the Fremedica global market. Andy Parkins-Entrepreneur and technology innovator: Andy is the Founder and CEO of Six Factor, Google's leading cloud partner in Western Canada. Over more than 25 years of developing technology solutions for business, he has led an array of global institutions in transforming and evolving their operations into world-class, client-centric product and service providers. Andy has held prominent leadership roles at the Insurance Corporation of British Columbia, Deloitte, the Monitise Group, the Royal Bank of Scotland, Qantas and Computer Visionwhere. He speaks at conferences on how businesses are delivering the leaders of tomorrow, and how converging technologies are transforming its world. New Risk • Sep 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-CA$385k). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (CA$744k revenue, or US$545k). Market cap is less than US$10m (CA$3.11m market cap, or US$2.28m). Minor Risk Shareholders have been diluted in the past year (13% increase in shares outstanding). Reported Earnings • Sep 01
Second quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 2Q 2022) Second quarter 2023 results: CA$0.01 loss per share (improved from CA$0.014 loss in 2Q 2022). Revenue: CA$193.0k (up 43% from 2Q 2022). Net loss: CA$328.8k (loss narrowed 35% from 2Q 2022). Tillkännagivande • Aug 07
Frequency Exchange Corp. announced that it expects to receive CAD 0.5 million in funding Frequency Exchange Corp. announced a private placement of up to 5 million units at a price of CAD 0.10 per unit for gross proceeds of up to CAD 500,000 on August 5, 2023. Each unit consists of one common share and one common share purchase warrant having an exercise price of CAD 0.15 per warrant and a term of 24 months from the date of closing of the transaction. During the 24-month period following the closing date, the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least CAD 0.50 per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company. The transaction is subject to TSX Venture Exchange approval and all securities issued will be subject to a four-month hold period. Reported Earnings • Jun 03
First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.10 loss in 1Q 2022) First quarter 2023 results: CA$0.01 loss per share (improved from CA$0.10 loss in 1Q 2022). Revenue: CA$217.4k (down 5.6% from 1Q 2022). Net loss: CA$399.8k (loss narrowed 88% from 1Q 2022). Tillkännagivande • May 27
Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023 Frequency Exchange Corp., Annual General Meeting, Jul 25, 2023. Reported Earnings • Apr 29
Full year 2022 earnings released: CA$0.14 loss per share (vs CA$0.076 loss in FY 2021) Full year 2022 results: CA$0.14 loss per share (further deteriorated from CA$0.076 loss in FY 2021). Revenue: CA$699.1k (down 29% from FY 2021). Net loss: CA$4.86m (loss widened CA$4.10m from FY 2021). Board Change • Jan 25
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jan 21
FREmedica Technologies Inc. Appoints Jeff Barnes as Chief Marketing Officer Frequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. has extended their relationship with Jeff Barnes, founding partner of the Angel Investor Network to continue as Chief Marketing Officer to launch NIKKI, a wearable frequency delivery system that supports recovery from wellness and performance issues during sleep. In addition to his long history in marketing, Jeff also worked as a nuclear power plant operator on a submarine in the U.S. Navy, acquiring a unique perspective on new technologies and a strong under standing of how they work. As a two-time best-selling author, he has helped businesses generate over $100 million in revenue and startups raise over $1 billion in funding during the course of his career. Reported Earnings • Dec 01
Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.009 loss in 3Q 2021) Third quarter 2022 results: CA$0.013 loss per share (further deteriorated from CA$0.009 loss in 3Q 2021). Revenue: CA$123.1k (down 42% from 3Q 2021). Net loss: CA$457.6k (loss widened 181% from 3Q 2021). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Nov 05
Fremedica Technologies Inc. Launches Nikki, A Frequency Delivery System That You Wear FREmedica Technologies Inc. has launched NIKKI, a Frequency Delivery System that supports recovery from wellness and performance issues while you sleep, into Canada USA and Europe. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day that may cause fatigue, pain, stress which will all affect your sleep. Tillkännagivande • Oct 29
FREmedica Technologies Inc. Announces Launch Date for NIKKI FREmedica Technologies Inc. announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while one sleeps. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of 37 trillion cells. NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. Reservations for an initial run of 5,000 NIKKI devices are being taken at www.WeAreNikki.com, with delivery scheduled for November. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night- Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120. Special offer ends December 1, 2022, when retail pricing goes into effect with a $10 monthly subscription for the additional frequencies. Tillkännagivande • Oct 28
Fremedica Launches Night-Time Wearable That Improves Cellular Function for Better Sleep, Less Pain, and More Energy Frequency Exchange Corp. announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), announces an October 31st launch date for NIKKI, a Frequency Deliver System that supports recovery from wellness and performance issues while sleep. Bioenergetics-based NIKKI emits frequencies that help restore cellular function within the body's network of37 trillion cells.NIKKI works at night to overcome physical and emotional trauma experienced during the day. In daytime mode, NIKKI offers a range of frequencies chosen to complement the day's issues and activities; from a stressful meeting to running a half-marathon. A $250 NIKKI early-adopter pre-release includes the NIKKI Gold package, with the device, lifetime access to the Night-Time frequency package and a one-year subscription to the Energy Boost, Stress and Anxiety, Pain Relief and Travel frequency programs at a savings of $120. Board Change • Oct 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Sep 15
FREmedica Technologies Inc. Announces Significant Proof of Concept Trial Results Frequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc., has completed a third-party ‘Quality of Life' Proof of Concept trial. The clinically validated, eight-week study demonstrated a significant improvement in 73% of participants, and some improvement in an additional 17% of participants using NIKKI and the Night-Time frequency package. NIKKI is a first-of-its-kind frequency emitter that delivers frequency packages into the body designed for wellness and performance enhancement. Reported Earnings • Sep 03
Second quarter 2022 earnings released: CA$0.014 loss per share (vs CA$0.016 loss in 2Q 2021) Second quarter 2022 results: CA$0.014 loss per share. Revenue: CA$134.8k (down 36% from 2Q 2021). Net loss: CA$508.9k (loss widened 212% from 2Q 2021). Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Board Change • Mar 28
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Board Change • Feb 09
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman & CEO Stephen Davis is the most experienced director on the board, commencing their role in 2019. Independent Director Brad Aelicks was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. 
